Cite
HARVARD Citation
Vandenberghe, R. et al. (2016). Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Alzheimer's research & therapy. 8 (1), pp. 1-13. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vandenberghe, R. et al. (2016). Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Alzheimer's research & therapy. 8 (1), pp. 1-13. [Online].